Breast Cancer, Lymphoma
Conditions
Keywords
Autologous Bone Marrow Transplant, Breast, Lymphoma, International travel, questionnaire, Hematopoietic Stem Cell Transplant (HSCT) recipients
Brief summary
This study also aims to raise awareness among both patients and health-care providers about the importance of pre-travel health consultation and preventive interventions prior to international travel. Through appropriate health counseling, cancer patients will have less risk of having travel -related health complications and thus have a better quality of life and overall improved sense of wellbeing.
Interventions
BEHAVIORALquestionnaires
The intervention is a self-administered anonymous questionnaire that is voluntarily completed by the patient. Questions in Section One will cover general information about the patient including gender, age, race, country of birth, current zip code of residence, and level of education. Questions in Section Two will cover information regarding the cancer (breast/lymphoma) or transplant (allogeneic/ autologous). Questions in Section Three will cover travel history including the frequency of travel outside the United States and Canada in the last 5 years. Questions in Sections Four through Seven will obtain information about their last trip outside the United States and Canada.
Sponsors
Memorial Sloan Kettering Cancer Center
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Hematopoietic Stem Cell Transplant (HSCT) recipients * Age \>18 years * Status post bone marrow transplant within last five years Breast Cancer patients: Criteria 1 and Criteria 2 and/or 3 * Female age \>18 years and current or past history of breast cancer * Received systemic chemotherapy in the last five years * Metastatic breast cancer disease (stage IV) Lymphoma: Criteria 1 and Criteria 2 and/or 3 * Age \>18 years and current or past history of lymphoma * Received systemic chemotherapy within 5 years * Had active disease at any time within the last 5 years
Exclusion criteria
* Patients age\< 18 years * Breast cancer and lymphoma patients in clinical remission in the past 5 years * Patients unable to fill the questionnaire due to language barriers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the frequency of international travel of the targeted patients in the last 5 years. | once at the time of the clinic visit |
Secondary
| Measure | Time frame |
|---|---|
| To determine if any of the international travel was during a high-risk specific period when the immune status of the target population was compromised. | once at the time of the clinic visit |
| To profile the target population who traveled internationally with respect to their demographic and cancer/transplant-related characteristics. | once at the time of the clinic visit |
| To obtain detailed information about their last international trip including | once at the time of the clinic visit |
| To assess the adequacy of the questionnaire instructions | once at the time of the clinic visit |
Countries
United States
Outcome results
None listed